GOSS vs ZBH · rev $26.2M vs P/E 23, rev $4.26B
Gossamer Bio Inc (GOSS) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported GOSS revenue for 2026-06-30 was $26.2M. Net income was -$29.8M. Revenue was up 54.5% from 2026-03-31 to 2026-06-30. GOSS currently screens at market cap $47.0M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
GOSS currently screens at market cap $47.0M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the GOSS and ZBH stock pages for the full models.
Not investment advice.